Kymera Therapeutics, Inc. (KYMR) is listed on NASDAQ in Biotech Stocks. It is $118.23, -1.66%, with a $9.8B market cap. RSI is 51.7, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 51.7 Neutral
Market Cap $9.8B
Volume 399.9K
Fundamentals — 10-Q Q2 2026
Revenue $99.4M
Net Income $-130.4M
EPS $-1.33
Gross Margin 0.0%
Operating Margin -160.8%
Net Margin -131.3%
P/E Ratio -88.9x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Mainolfi Nello | Chief Executive Officer | Sell | 50,000 | $119.00 | $6.0M | 2026 Jul 7 |
| Goodman Noah | Chief Business Officer | Sell | 3,389 | $114.29 | $387,329 | 2026 Jul 1 |
| Mainolfi Nello | Chief Executive Officer | Sell | 80,000 | $115.29 | $9.2M | 2026 Jul 1 |
| Jacobs Bruce N. | Chief Financial Officer | Sell | 77,109 | $114.96 | $8.9M | 2026 Jun 30 |
| Booth Bruce | Insider | Sell | 76,650 | $108.05 | $8.3M | 2026 Jun 29 |
| Booth Bruce | Insider | Sell | 31,283 | $109.48 | $3.4M | 2026 Jun 29 |
| Booth Bruce | Insider | Sell | 513,245 | $110.01 | $56.5M | 2026 Jun 29 |
| Bvf Partners L P/il | Director | Sell | 1,630,658 | $106.50 | $173.7M | 2026 Jun 26 |
| Booth Bruce | Insider | Sell | 285,684 | $121.86 | $34.8M | 2026 Jun 25 |
| Booth Bruce | Insider | Sell | 398,765 | $110.31 | $44.0M | 2026 Jun 25 |
| Goodman Noah | Chief Business Officer | Sell | 5,000 | $114.00 | $570,000 | 2026 Jun 25 |
| Booth Bruce | Insider | Sell | 31,798 | $103.75 | $3.3M | 2026 Jun 22 |
| Booth Bruce | Insider | Sell | 478,198 | $94.72 | $45.3M | 2026 Jun 22 |
| Goodman Noah | Chief Business Officer | Sell | 2,500 | $99.00 | $247,500 | 2026 Jun 22 |
| Chadwick Jeremy G | Chief Operating Officer | Sell | 17,184 | $79.92 | $1.4M | 2026 May 27 |
| Ridloff Elena | Insider | Sell | 3,000 | $87.00 | $261,000 | 2026 May 11 |
| Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $81.18 | $2.4M | 2026 Apr 29 |
| Booth Bruce | Insider | Sell | 6,000 | $89.96 | $539,772 | 2026 Apr 22 |
| Chadwick Jeremy G | Chief Operating Officer | Sell | 300 | $90.00 | $27,000 | 2026 Apr 22 |
| Chadwick Jeremy G | Chief Operating Officer | Sell | 6,551 | $90.00 | $589,598 | 2026 Apr 15 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $54.45 | 50.2 | $13.5B |
| | $43.12 | 53.6 | -- |
| | $8.05 | 54.2 | $8.5B |
| | $351.70 | 55.2 | $10.4B |
Take KYMR further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put KYMR in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Kymera Therapeutics, Inc. next reports.
Set alerts on KYMR
Get notified when Kymera Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free